Fig. 5

Overview of selected monitoring variables. An overview of selected variables (y-axis; neuromuscular performance, well-being, CK, cfDNA) at time points (x-axis) at rest. The VAS (well-being) scores should be understood such that a higher score indicates a decrease in well-being. Biomarker monitoring in the present case was measured at selected time points during the intervention phase and will be extended to a daily assessment in the upcoming study